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Available online 7 July 2016Background: Cognitive impairments contribute signiﬁcantly to disease burden in young individuals presenting
with major psychiatric disorders. The capacity to encode the consequences of one's actions may be of particular
importance for real-world functioning due to its fundamental role in goal-directed behavior.
Methods:Here, we investigated a dimensionalmeasure of causal awareness during a probabilistic learning task in
92 young individuals with an admixture of major mood and psychotic illnesses, at early and more established
stages. Using automated graymatter segmentation of T1-weighted images, we estimated the volume and shapes
of major subcortical structures and investigated their association with causal awareness.
Results: The low causal awareness (LCA) group (n= 35) reported increased social disability (p= .004) and re-
duced right pallidal size, speciﬁcally within the dorsolateral surfaces (p= .02), relative to the unimpaired high
causal awareness (HCA) patients (n=57). In early-stage illness, LCA had a smaller right thalamus (p= .002) rel-
ative to HCA. Exploratory investigations suggested that in developed psychotic syndromes, causal awarenesswas
correlated with left hippocampal size (p= .006) whereas, in more persistent affective disorders, causal aware-
ness was correlated with left amygdala size (p= .013), speciﬁcally within the anterior aspect.
Discussion: Low causal awareness occurs across diagnoses and stages of illness and is associated with poor func-
tional outcomes. Our results suggest that theremaybe sharedneural underpinnings of its dysfunction in the early
course of mood and psychotic disorders, however inmore established illness, there is greater neurobiological di-
vergence in causal awareness correlates between diagnoses.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Youth1. Introduction
Major psychiatric illnesses typically emerge between the ages of 15
and 30 (Kessler et al., 2005; Paus et al., 2008), which is a key period of
social, academic and occupational development. Identifying factors
thatworsen the clinical and real-world functioning for these individuals
is a crucial step towards early intervention strategies that enhance qual-
ity of life and reduce socio-economic burden.
Cognitive impairments have been shown to contribute signiﬁcantly
to functional disability across early stage bipolar disorder (Lee et al.,
2014; Lin et al., 2011), schizophrenia (Allott et al., 2011; Lin et al.,
2011) and depression (Bora et al., 2013; Lee et al., 2012). Importantly,
traditional neuropsychological functions such as working memory andl 6, 94Mallett St, Camperdown,
. Balleine).
NSW, Kensington, NSW 2052,
. This is an open access article underexecutive processes are reported to be better predictors of future func-
tional outcomes than diagnostic category (Lee et al., 2013; Simonsen et
al., 2010; Torres et al., 2010). The capacity to encode the consequences
of one's actions is a fundamental capacity that draws upon these cogni-
tive processes. It is critical for goal-directed behavior, allowing adapta-
tion to changing environments so as to achieve desirable outcomes
and avoid aversive ones (Balleine and Dickinson, 1998). Importantly, a
reduced capacity for goal-directed behavior has also been associated
with poor response to cognitive-behavior therapy (CBT) in patients
with social anxiety disorder (Alvares et al., 2014). This highlights how
causal knowledge may not only impact social and occupational out-
comes by guiding optimal choices, but may also affect the efﬁcacy of
popular learning-based treatments for mental disorders.
Previous functional imaging studies in healthy subjects have demon-
strated that a network including the medial prefrontal cortex (mPFC)
and the anterior caudate nucleus (aCN)mediates learning of action-out-
come contingencies (Liljeholm et al., 2011; Tanaka et al., 2008). Disrup-
tion within these regions, or within the subcortical feedback loops (e.g.
pallidum, thalamus) connecting these regions, may contribute to causalthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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external globus pallidus were associated with altered causal awareness
in youth with depression (Grifﬁths et al., 2015).
Finding links between dimensional behavior and speciﬁc neural net-
works is a critical step towards an individualized understanding of com-
promised functioning, and may contribute to efforts in developing
targeted treatment strategies (Insel, 2007).
During the early stages of mental illness, disorders commonly pres-
ent with an admixture of clinical symptoms (e.g. anxiety, depression
and general distress) and, as such, a reliable diagnosis is often difﬁcult
(Hermens et al., 2011). For this reason, it is particularly important to
be able to identify behavioral or brain markers that are common across
diagnoses, which may have greater utility in prognosis and predicting
functional outcomes, especially during the early stages when illness
characteristics are less entrenched (McGorry et al., 2006).
The relationship between causal awareness and brain structurewith
respect to stage of illness is unknown. In keepingwith the Research Do-
main Criteria (RDoC; Insel et al., 2010), our overarching objectivewas to
determinewhether causal awareness is a functionally-relevant and bio-
logically-speciﬁc endophenotype that cuts across traditional diagnostic
boundaries and stage of illness. As such, the current study sought to de-
termine whether causal awareness deﬁcits are evident within early
stages of psychiatric illness, as well as across more established major
psychiatric disorders in adolescents and young adults. Secondly, we
aimed to investigate whether there is a common association between
poor causal awareness and differences in underlying cortical–basal gan-
glia structures, irrespective of stage of illness. This is important because
differences in neural structure may occur between individuals in earlier
phases of illness relative to those who have transitioned into more
established disorders (Lagopoulos et al. 2012; Pantelis et al., 2003). As
such, it is unclear if the relationship between causal awareness and spe-
ciﬁc structures may differ with early or later stage illness.
2. Methods
2.1. Demographics and clinical assessments
2.1.1. Participants
Ninety-two outpatients (aged 14–33 years) were recruited from
specialized assessment and early intervention services for mental
health problems in young people (headspace at the Brain andMind Re-
search Institute (Scott et al., 2012). Twenty demographically similar
healthy controls were also recruited from the same geographical catch-
ment area. Exclusion criteria for both clinical and control groups were
history of neurological disease (e.g. head trauma, epilepsy), intellectual
and/or developmental disability as reported to referring clinicians or re-
search psychologists, and/or insufﬁcient English language skills. A re-
search psychologist screened controls for psychopathology via clinical
interview. All patients continued to receive ‘treatment as usual’ with
no interference to their prescribed course of treatment. All participants
(and guardians if participants were b16 years) gave written informed
consent. The study was approved by the University of Sydney ethics
committee and the investigation was carried out in accordance with
the latest version of the Declaration of Helsinki.
2.1.2. Clinical and neuropsychological assessment
All participants underwent clinical and neuropsychological assess-
ment as previously described (Lee et al., 2015; Scott et al., 2012).
Patients were seeking help primary for a unipolar depressive disorder
(n = 50), bipolar disorder (n = 22), and/or a psychotic syndrome
(ﬁrst-episode psychosis, schizophrenia, schizoaffective disorder)
(n = 19). Research psychologists rated clinical symptoms using the
Brief Psychiatric Rating Scale (Overall andGorham, 1962), HamiltonDe-
pressive Rating Scale (Hamilton, 1967) and Young Mania Rating Scale
(Young et al., 1978). Positive, negative, depressive, andmanic symptom
sub-scores of the BPRS were also calculated (Dingemans et al., 1995).Real-world functioning was indexed using the observer-rated Social
and Occupational Functioning Assessment Scale (SOFAS; Goldman et
al., 2012) and the patient-rated World Health Organization Disability
Assessment Scale version 2 (WHODAS-II; Chwastiak and Von Korff,
2003). Premorbid intelligence (‘predicted IQ’) was estimated based on
performance on the Wechsler Test of Adult Reading (WTAR;
Wechsler, 2001).
2.1.3. Clinical staging
All patients were assigned an illness stage according to a clinical
staging model (c.f. see Appendix 1 in Hickie et al., 2013 for details), ac-
cording to consensus between experienced clinical researchers. Clinical
staging involves a detailed description ofwhere an individual exists on a
continuum of disorder progression from stage 0 (an at-risk or latency
stage) through to stage IV (late or end-stage disease) (Scott et al.,
2013). Using this model, individuals may be classiﬁed as: stage 1a =
‘help-seeking’; stage 1b = ‘attenuated syndrome’; stage 2 = ‘discrete
disorder’; stage 3= ‘recurrent or persistent disorder’; and stage 4= ‘se-
vere, persistent and unremitting illness’. Stage 1b is assigned when the
individual has developed sub-threshold symptoms of anxiety, depres-
sion, hypomania and/or psychotic phenomena. It encompasses the
symptoms, disability and need for care that typically are below the
thresholds required by current diagnostic systems (e.g. brief or recur-
rent hypomania, disrupted sleep-wake cycle, increased or decreased en-
ergy). Stage 2 is assigned when the individual displays a full-threshold/
frank psychotic, manic and/or severe depressive episode, and stage 3
when these symptoms persist or are recurrent (cf. Hickie et al., 2013:
see Appendix 1—template used by clinicians to reach staging decisions;
and Appendix 2—a guide linking supporting standard assessments and
clinical measures to stage in Hickie et al., 2013 for details). Importantly,
stage does not necessarily correlatewith duration of illness or age. Some
Stage 1b individuals may never progress to stage 2, while others may
transition almost immediately.
In order to determine whether stage of illness affected relationships
between causal awareness and subcortical structure volumes, the pa-
tient sample was classiﬁed as being within either the early (1b) or
later stages (2 or 3) of illness. These stages were selected as they ac-
count for the majority of the adolescent and young adult patients at
headspace (Scott et al., 2012).
2.2. Causal awareness task
The instrumental causal awareness task involved participants choos-
ing between two actions (AHIGH or ALOW) in order to earn food rewards
(chocolate or crackers) (see Fig. 1). During each block, reward was al-
ways more contingent on one action (AHIGH) than the other action
(ALOW). Across blocks, AHIGH switched location (left or right), and the re-
ward ratio schedule varied (0.25, 0.125, 0.08). The schedule of ALOW al-
ways remained at 0.05, thus the relative difference in contingency
between actions was altered, allowing us to assay sensitivity to these
changes. Responding was self-paced during the 12 blocks, each 40-s in
length. At the end of each block, participants were asked to judge, on a
10-point Likert scale, how likely it was that pressing each button earned
them rewards on the previous trial (0—not at all likely, 10—extremely
likely). The task began with a 0.25 contingency practice block, followed
by ratings of pre-task hunger (0, not hungry at all, to 10, extremely hun-
gry) and pleasantness of each food outcome (−5, not at all pleasant, to
+5, extremely pleasant). Participants were made aware that they
would be given the food rewards that they had earned at the end of
the task.
Choice performance and causal awareness were computed by aver-
aging the proportion of optimal key choices and optimal key ratings
(AHIGH/AHIGH + ALOW) from the three contingency conditions. Partici-
pants with a causal awareness metric 1SD or more below the healthy
control group mean were classed as low causal awareness (LCA) with
the remaining individuals classiﬁed as high causal awareness (HCA).
Fig. 1. Experimental task. Participants were able to choose between two buttons, to maximize reward. Unsuccessful button presses were signaled by a gray circle, while rewarded
responses were signaled by a 1000 ms reward stimulus presentation, and the responsible button was highlighted green. After each block of trials, participants rated how causal each
button was.
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group of interest, youth with psychiatric illness and low causal aware-
ness, and to compare them to the most robust control group: youth
with psychiatric illness with non-impaired causal awareness.
Statistical analyses were performed using IBM SPSS 22.0 (SPSS Inc.,
Chicago). Analyses of variance (ANOVAs) and Pearson's chi squared
tests were used to examine group differences in demographics, clinical
factors and contingency task performance. Assumptions of normality
were assessed using Kolmogorov–Smirnov tests and equality of vari-
ance was assessed using Levene's test. For any signiﬁcant group differ-
ences (LCA v HCA), Pearson correlations were conducted to further
examine the associationwith causal awareness as a continuous variable.
Alpha levels were set at 0.05 (2 tailed).
2.3. Image acquisition
Participants underwent structural MRI scanning using a 3-Tesla GE
MR750 scanner at the Brain andMind Research Institute, Camperdown,
NSW Australia. Images were acquired using an optimized MP-RAGE 3D
T1-weighted sequence to resolve anatomy at high resolution (0.9 mm
isotropic resolution); TR = 726 ms; TE = 2784 ms; ﬂip angle = 10°;
coronal orientation; FOV 230 mm3; matrix of 256 × 256 × 196.
FSL (FMRIB Software Library) tools (www.fmrib.ox.ac.uk)were used
in all analyses (version 5.0.1).
2.4. Structural imaging analysis
Two T1-weighted structural scans obtained from a single scanning
session were averaged for each individual to increase signal-to-noise
ratio. Non-brain material was removed (FSL BET; Smith, 2002), then
T1-weighted images were transformed into standard space using a lim-
ited degrees-of-freedom non-linear model to ensure spatial alignment
and images were corrected for non-uniformity.
2.4.1. Volumetrics
Volumetric data were obtained using FIRST (Patenaude et al., 2011)
to automatically segment the following sub-cortical regions: bilateral
amygdala, caudate nucleus, putamen, pallidum, thalamus and hippo-
campus. The caudate, pallidum and thalamus were selected due to evi-
dence that the mPFC-caudate and feedback loops are involved in
learning action-outcome contingencies (Grifﬁths et al., 2015;
Liljeholm et al., 2011). The hippocampusmay be important formapping
reward values to spatial locations (Izquierdo et al., 2006), while thenucleus accumbens and amygdala have important roles for assessing
and utilizing current outcome value in choice situations (Grifﬁths et
al., 2013).
Tissue-type segmentation carried out using FAST4 was used to cal-
culate intracranial volumes (ICV), whichwere used to correct for differ-
ences in head size. These region of interest (ROI) volumes were then
corrected for ICV variation so as to provide a common space for cross-
sectional morphometric comparisons. Volumetric differences between
LCA and HCA were assessed using independent-samples t-tests. For
any signiﬁcant group differences, associations between causal aware-
ness and sub-cortical volumewere further examined using Pearson cor-
relations. Bonferroni corrections were applied to account for
comparisons across multiple regions (.05/12 regions = .004).
2.4.2. Shape analysis
FIRST created a surface mesh for the subcortical structure in each
subject, which was reconstructed in MNI space to normalize for inter-
individual head size differences. Pose (rotation and translation) was re-
moved byminimizing the sumof squares difference between the corre-
sponding vertices of a subject's surface and the mean surface.
Correlations between causal awareness and ROI shape were assessed
within the whole patient group on a per-vertex basis using permuta-
tion-based GLM. Differences between groups were assessed on a per-
vertex basis using F statistics. The directionality of signiﬁcant F-tests
was investigated using t-tests.
3. Results
3.1. Causal awareness and clinical associations
Thirty-ﬁve participants (38%) met criteria for low causal awareness
(LCA), with the remaining individuals classed as high causal awareness
(HCA) (n = 57, 62%). The LCA and HCA patient groups did not differ
with regard to age, gender, years of education, predicted IQ, duration
of illness, age of illness onset, medication-use, or any clinical symptoms
on the BPRS or YMRS, p N .05. Controls (CON) (n=20) however had sig-
niﬁcantly greater years of educational attainment than LCA, (F(2109)=
4.3, p = .019. LCA made signiﬁcantly poorer causal judgments and
fewer optimal choices than both HCA and CON (see Table 1). There
were no signiﬁcant differences in causal awareness or proportion of op-
timal choices between HCA and CON groups. Fifty-ﬁve patients were
identiﬁed as being within the early stage (1b), while 33 were rated
within the later stages of illness (2 or 3).
Table 1
Demographic and clinical characteristics of participants. Means ± SD.
LCA
(n= 35)
HCA
(n= 57)
CON
(n= 20) F/X2 (p)
Demographics
Female N (%) 25 (71%) 19 (54%) 11 (55%) 2.57 (.28)
Age (years) 21.4 ± 4.3 23.1 ± 4.9 23.9 ± 2.4 2.86 (.06)
Education 12.3 ± 2.6 a 13.2 ± 2.5 14.4 ± 2.4 a 4.3 (.02)*
Predicted IQ 105.0 ± 7.5 107.2 ± 6.4 106.4 ± 8.2 0.79 (.46)
Symptoms and history
Age of onset (years) 15.5 ± 3.2 15.7 ± 5.5 0.01 (.91)
Duration of illness (years) 6.3 ± 3.9 7.5 ± 4.2 1.43 (.24)
WHO-DAS disability participating in society 45.7 ± 17.7 35.3 ± 16.6 2.94 (.004)
Medication
N(%) of cases medicated 27 (77.1%) 43 (75.4%) .035 (1.0)
N(%) on antidepressants 20 (57.1%) 29 (50.9%) .34 (.67)
N(%) on mood stabilizers/anticonvulsants 10 (28.5%) 13 (22.8%) .38 (.62)
N(%) on antipsychotics 14 (40.0%) 19 (33.3%) .41 (.66)
N(%) on anxiolytics 1 (2.8%) 3 (5.2%) .36 (1.0)
Task performance
Causal judgments 0.56 ± 0.1 0.68 ± 0.1 0.67 ± 0.1 53.80 (b .001)
Optimal choices 0.52 ± 0.1 0.59 ± 0.1 0.61 ± 0.1 7.59 (b .001)
Motivation measures
Hunger (0–10) 5.2 ± 1.8 5.9 ± 2.7 6.3 ± 1.6 1.60 (.21)
Food ratings (−5: +5) 2.5 ± 1.7 2.1 ± 2.0 3.0 ± 1.4 1.78 (.18)
Press rate (per s) 1.3 ± 0.4 1.4 ± 0.4 1.42 ± 0.4 0.78 (.47)
HC, healthy controls; World Health Organisation Disability Assessment Scale. NB. Duration of illness indicates time since patient ﬁrst experienced mental health problems, not time since
diagnosis. *denotes b .05).
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of those with bipolar disorder, and 47% with a psychotic disorder. The
proportion of individuals with low causal awareness did not differ sta-
tistically across diagnostic categories, X2(2) = .81, p = .67. Similarly,
the proportion of individuals with low causal awareness did not differ
across early (39%and later (36%stages of illness, X2(1) = .06, p= .82.
3.2. Causal awareness and real-world functioning
To investigate the functional associations of causal awareness, we
compared LCA and HCA on the SOFAS and WHODAS-II. LCA reported
higher levels of disability ‘participating in society’ relative to the HCA,
t(79) = 2.94, p = .004. Using causal awareness as a continuous mea-
sure, reductions in causal awareness were signiﬁcantly associated
with increased self-reported total disability (r=−.26, p= .04) and re-
duced clinician-rated social and occupational functioning (r= .26, p=
.033) (Fig. 2).
3.3. Sub-cortical differences in participants with low causal awareness
T1-weighted images were not obtained from 4 patients due to scan-
ning artifacts or missing data. LCA had smaller mean right pallidum sizeFig. 2. Causal awareness, disability, and social and occupational functioning. Patients with grea
and occupational functioning.than HCA, t(86) = 0.2, p= .038, which was supported by a positive as-
sociation between causal awareness and right pallidal size in the whole
patient group, r = .25, p = .02, though these results did not survive
stringent Bonferroni correction (p= .004). There were no other signif-
icant differences in any other subcortical region (Table 2). Shape analy-
sis determined that the correlation between causal awareness and right
pallidal size was speciﬁcally associated with an inward movement of
vertices on the central region of the right pallidum, on the lateral aspect
(p = 0.02) (Fig. 3). This is situated within the globus pallidus externa
(GPe). This ﬁndingwas replicated using our causal awareness classiﬁca-
tion groupings, ruling out an effect due to covariance in symptomology
or other matched factors.
3.4. Sub-cortical associations with causal awareness according to stage of
illness
For those within an earlier stage of illness (1b), HCA and LCA groups
remained matched on all demographic and clinical variables.LCA had a
smaller right amygdala, t(53) = −2.0, p = .047, right pallidum,
t(30.8) =−2.2, p= .04, and right thalamus, t(53) =−3.2, p= .002,
relative to HCA (note that only the right thalamic size group difference
survives Bonferroni multiple comparisons correction (p= .004)). Thister causal awareness tended to have reduced levels of disability and higher levels of social
Table 2
ICV-corrected volumetric data of ROIs; mean ± SEM (mm3).
LCA HCA CON
Left hemisphere Caudate 3770 ± 58 3831 ± 69 3822 ± 69
Putamen 4911 ± 73 4918 ± 58 4922 ± 59
Pallidum 1676 ± 19 1676 ± 21 1725 ± 71
Thalamus 8069 ± 73 8190 ± 71 8391 ± 119
Amygdala 1208 ± 36 1245 ± 25 1289 ± 43
Hippocampus 3611 ± 67 3684 ± 68 3750 ± 89
Right hemisphere Caudate 3924 ± 70 4022 ± 82 4035 ± 100
Putamen 4820 ± 70 4939 ± 53 4950 ± 54
Pallidum 1656 ± 25 1725 ± 27 1716 ± 27
Thalamus 7848 ± 84 8031 ± 68 8173 ± 99
Amygdala 1253 ± 33 1316 ± 24 1229 ± 44
Hippocampus 3789 ± 78 3833 ± 65 3828 ± 91
Comparison of ICV corrected volumes showed larger mean right pallidal size in HCA rela-
tive to LCA. This did not survive correction for multiple comparisons. N.B. Control sub-cor-
tical volumes are included to provide a normative reference point.
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volumes within a right lateralized circuit containing the pallidum
(r = .37, p = .006), thalamus (r = .32, p = .018), and the amygdala
(r= .35, p= .008) (Fig. 4). For those rated in a later stage (i.e. 2 or 3)
of illness however, no subcortical structures size were correlated with
causal awareness. As an exploratory investigation, we split the later
stage group into affective (depression and bipolar disorderwithout psy-
chosis) versus psychosis (schizophrenia, ﬁrst episode psychosis,
schizoaffective disorder, bipolar disorder with psychosis) groups. In
the later stage psychosis group (n= 21), there was a positive relation-
ship between causal awareness and left hippocampal size, r= .59, p=
.006, while in the affective group (n=12), there was a positive correla-
tion between causal awareness and left amygdala size, r=.67, p=.013.
Shape analysis revealed that this correlation was speciﬁc to the anterior
surface of the left amygdala (Fig. 4).4. Discussion
4.1. Reduced volume within right external pallidum in participants with
low causal awareness
Cognitive deﬁcits and structural changes within the cortical–basal
ganglia network are shared illness characteristics across major mood
and psychotic disorders. Here, we sought to compare adolescents and
young adults with psychiatric illnesses on the basis of awareness of
the causal efﬁcacy of their actions. Despite equivalence on all demo-
graphic and clinical measures, two key differences emerged in the low
causal awareness group relative to patients unimpaired in this capacity:
the LCA group reported increased social disability and exhibited re-
duced right pallidal size. Speciﬁcally, LCA had inverted vertices on the
dorsolateral pallidal surfaces relative to HCA. In early stage psychiatricFig. 3. Causal awareness and subcortical volume and shape in youth with psychiatric illnesses. A
Vertex-wise shape analysis. Average shape of the right pallidum in all patients (blue), with or
vertices relative to HCA. Image shows varying rotations of a 3D MNI template brain, with the rillness, LCA exhibited reduced size of the right thalamus relative to
HCA. Exploratory investigations suggest that for those with later stage
psychosis, causal awareness was positively correlated with left hippo-
campal size, whereas in later stage affective disorders, causal awareness
was positively correlated with left amygdala size, speciﬁcally with the
anterior aspect. In summary, although deﬁcits in causal awareness
were found to occur to a similar extent across the early and later stages
of illness, there were differences in the underlying neurobiological
correlates.4.2. Reduced causal awareness as a trans-diagnostic impairment
As discussed recently by Robbins et al. (2012), there is an urgent
need to identify neurocognitive endophenotypes that can be applied
trans-diagnostically. Our results show that almost 40% of young individ-
ualswith psychiatric disorders experience a commondifﬁculty in recog-
nizing the consequences of their actions, irrespective of diagnosis,
illness severity or stage of illness. Although not statistically signiﬁcant,
a larger proportion of individuals with psychosis demonstrated low
causal awareness relative to those with depression or bipolar disorder.
This is consistent with previous reports of general cognitive deﬁcits
often being greater in psychotic cohorts compared with the affective
disorders (Hellvin et al., 2012; Reppermund et al., 2009; Simonsen et
al., 2010). While this measure identiﬁes individuals with a similar be-
havioral deﬁcit across diagnosis and stage of illness, its neural correlates
are not consistent, likely ruling it out as an endophenotype with a
shared genetic mechanism.
Importantly though, the early identiﬁcation of problems with
encoding the causal consequences of one's actions may have relevance
for guiding clinical treatment decisions. Reduced causal awareness
was associatedwith increased social and occupational dysfunction, sug-
gesting that thismay represent a useful cognitivemarker for identifying
individuals who require additional social support. In addition, reduced
causal awareness may impact on the efﬁcacy of speciﬁc treatments. In-
dividuals with social anxiety and a reduced capacity for goal-directed
behavior experienced poorer response to CBT (Alvares et al., 2014).
For these individuals steps may need to be taken to target the updating
of belief systems, or alternate therapies may need to be considered. The
relationship between altered causal awareness and response to cogni-
tive therapies is clinically important and requires further investigation.
We failed to ﬁnd any signiﬁcant association between causal aware-
ness and clinical symptoms such as depression, psychosis, or anxiety.
This supports previous ﬁndings that clinical symptomology and cogni-
tion may to some extent lie on separate dimensions (i.e. Bora et al.,
2013; Lee et al., 2012). Although psychosis, mania, depression and anx-
iety have been shown to introduce state-based cognitive impairments
(Millan et al., 2012), when acute clinical symptoms abate, cognitive def-
icits often persist (Bora et al., 2013). Importantly however, as reduced
causal awareness was associated with poorer real-world functioning,. Positive correlation between contingency awareness and volume of the right pallidum B.
ange regions representing surfaces where individuals with LCA had an inward location of
ight hemisphere cut away to reveal the 3D mesh of the pallidum.
Fig. 4. Associations between causal awareness and subcortical structure sizes in the early and later stages of illness. Top panel. Within our group of sub-syndromal helping-seeking
participants, causal awareness was positively correlated with the size of right amygdala, pallidum and thalamus. Bottom panel. Within later stage psychosis, causal awareness was
positively correlated with left hippocampal size, while in later stage affective disorders, causal awareness was positively correlated with left amygdala size. On the right, the average
shape of the left amygdala in all later stage affective disorder individuals is depicted in blue, with orange regions representing surfaces where individuals with lower causal awareness
had an inward location of vertices. Image shows a 3D MNI template brain, with the left hemisphere cut away to reveal the 3D mesh of the amygdala.
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gression to more severe psychopathology (Lin et al., 2013;
Martinez-Aran et al., 2004).
4.3. Neural correlates of causal awareness
Tracking of action-outcome contingencies has previously been
shown to be modulated by neural circuits including the mPFC and cau-
date nuclei (Liljeholm et al., 2011; Tanaka et al., 2008)—regions that are
connected by wider basal ganglia loops. Our results indicated that those
with low causal awareness had reduced right pallidal volumes, speciﬁ-
cally in the central region of the pallidum (anterior–posterior axis) on
the lateral aspects. This replicates our recent ﬁnding that volumetric re-
duction within the indirect pathway involving the right dorsolateral
pallidum is associated with reduced awareness of the causal efﬁcacy
of goal-directed actions in young depressed individuals (Grifﬁths et al.,
2015), and extends this ﬁnding by showing that it is not speciﬁc to
depression.
Targeting adolescents and young adults enabled us to examine indi-
viduals in the earlier, often less differentiated phases of mental illness
when diagnosis is less reliable (Bromet et al., 2011). Despite low rates
of conversion from an ultra high-risk (UHR) state to an established dis-
order (Simon et al., 2011), UHR groups exhibit discernible differences
from controls in both gray matter and white matter morphology
(Lagopoulos et al., 2013; Lagopoulos et al. 2012). Further, in this early
stage, affective and psychotic disorders share signiﬁcantly overlapping
neurobiological changes relative to controls. Within early stage individ-
uals in the current study, the low causal awareness group had reduced
right thalamic size relative to the high causal awareness group. The
mediodorsal thalamus is an important relay structure between thestriatum and prefrontal cortex (Parnaudeau et al., 2013), therefore dys-
function here may also disrupt other prefrontal-dependent cognitive
behavior. Although the ﬁndings did not survive Bonferrroni correction,
volumes of the right pallidum and amygdala were also reduced in the
low causal awareness group. Causal awareness was positively correlat-
ed with structural size in this extended right lateralized circuit, includ-
ing pallidum, amygdala and thalamus, suggesting that volume
reductionswithin this circuitmay be associatedwith generalized cogni-
tive impairment. Later stage illnessmay however exhibit greater neuro-
biological divergence between diagnoses, and pathophysiology more
typical of established, older cohorts.Within later stage psychosis, causal
awareness was correlated with left hippocampal size, and in affective
disorders, with left amygdala size, speciﬁcally on the anterior aspects.
Hippocampal pathology in schizophrenia has been well established
across a range of imaging modalities and post-mortem studies
(Adriano et al., 2012; Heckers, 2001) and the hippocampal-striatum cir-
cuit has previously been found to be important for learning to map spa-
tial locations onto reward values (Izquierdo et al., 2006; Rossato et al.,
2006). Alternatively, retrospective causal ratings may rely upon con-
text-dependent episodic memory, which the left hippocampus is
thought to modulate (Burgess et al., 2002). Depression has been often
been associated with volumetric abnormality in the amygdala
(Hamilton et al., 2008). Interestingly, exploratory investigations
showed that causal awareness was correlated speciﬁcally with surface
vertices on the anterior aspects of the structure, whichmay correspond
to the basolateral amygdala (BLA). This region is a key part of evaluative
learning circuitry, and plays a fundamental role in linking value infor-
mation with the sensory features of reward or reward-related cues
(Balleine et al., 2003). Impairments in this regionmight critically impact
value based learning as well as causal awareness.
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As for many studies using heterogeneous clinical groups, we should
be cautious in interpreting graymatter volumes in a cohort treatedwith
variousmedication classes. For instance, it is well documented that lith-
ium increases gray matter volumes (Moore et al., 2000) while atypical
antipsychotics are associated with thalamic enlargement (Dazzan et
al., 2005). It is possible that medications for speciﬁc symptoms (e.g. an-
tipsychotic or antidepressant) may contribute to the differentiation in
neural correlates of causal awareness in later stage psychotic and affec-
tive disorders. Longitudinal data is necessary however for makingmore
substantiated claims about illness progression. Thiswould also allow for
a better understanding of the causal nature of the association between
causal awareness and real-world functioning and an examination of
modulatory effects on treatment outcomes. Due to the relatively small
sample size, our exploratory ﬁndings need to also be replicated in larger
samples before ﬁrm conclusions can be drawn. Futureworkmay beneﬁt
fromutilizing a battery of behavioral tests designed to dissociate deﬁcits
in speciﬁc aspects of goal-directed behavior more broadly (see Balleine
and O'Doherty, 2010). This may assist with identifying individual-spe-
ciﬁc deﬁcits which may lead to targeted pharmacological treatment.
4.5. Summary and conclusion
Gauging the consequences of one's actions relies upon a broad neu-
ral network that integrates capacities such as learning, memory and ex-
ecutive functioning. Given this complexity, aiming to determine
underlying pathology from a single behavioral metric may appear be-
yond current methodology. Nevertheless, poor causal awareness ap-
pears to be a cross-diagnostic impairment that was associated with
social functioning. Early identiﬁcation of problems such as these may
provide impetus for targeted cognitive interventions, to ultimately re-
duce disease burden or delay the development of full threshold disor-
ders. On balance, causal awareness is a functionally relevant
dimensional capacity, however further research is necessary to clarify
the underlying individual-speciﬁc neural correlates.
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